Page 246 - Total War on PTSD

Over the past few years we’ve tried many modalities to treat those suffering, and it often felt like the lyrics of Sam Hunt’s song: ‘Body like a back road, drivin’ with my eyes closed.’ There are many programs offering treatment, but the proper selection of psychiatric medications for specific patients has not had a solid scientific basis. We are using Genomind’s Genecept Assay as well as Assurex’s Genesight to help treat those suffering from PTSD, and the future is starting to look brighter.
Genecept Assay Test
This is a test used in the decision-making process when prescribing medication and treatment for psychiatric conditions. Genecept looks at pharmacodynamic gene variations and drug target sites and how they differ among individuals.
According to: https://genomind.com/the-genecept-assay/clinicians/faq/
How does the Genecept Assay Test work?
It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions. Genecept is used to guide treatment for a range of psychiatric conditions including Depression, Anxiety, Obsessive-Compulsive Disorder (OCD), Attention Deficit Hyperactivity Disorder (ADHD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Autism, Schizophrenia, chronic pain and substance abuse. Each Assay provides clinicians with an easy to read patient report and a complimentary psychopharmacologist consultation.
Ketamine
246 of 1042